urban planning, Kendall Square, Cambridge Wade Roush wrote: Companies, merchants, and residents in the Kendall Square neighborhood of Cambridge banded together last week to form the Kendall Square Association, a non-profit group whose mission, according to its new president Tim Rowe, is to “im...

television, Internet, Advertising Wade Roush wrote: Back in November, we covered a Boston company called Backchannelmedia that’s giving broadcasters and advertisers a new marketing channel by adding a Web bookmarking function to TV programming. I stopped by Backchannelmedia’s office for ...

Biotech, pharma, acquisitions Wade Roush wrote: Zhoop! It’s the sound of another prominent local biotech company being acquired by a far-away pharmaceutical giant. Last week it was Millennium, which was snapped up by Japan’s Takeda Pharmaceuticals for $8.8 billion. This time it’s C...

Biotech, Genzyme, biogenerics Rebecca Zacks wrote: I’m always hesitant to try to read the tea leaves on the future of biogenerics—those would-be lower-cost copies of protein-based biotech drugs. After all, the question of if, when, and how the FDA would create a mechanism for approving s...

Robotics, logistics, warehousing Wade Roush wrote: Kiva Systems may be winning its battle against the science-fiction robots. The Woburn, MA, company is a newcomer to a hidebound business. It builds “mobile fulfillment systems” that are overturning all the traditions of warehousing by ma...

Games, VC, funding Wade Roush wrote: It’s a big day for the company formerly known as GuildCafe, which is announcing a new name—GamerDNA—and a new $3 million funding round from Flybridge Capital Partners (see main story). I interviewed GamerDNA founder and CEO (and avid gamer) Jon ...

energy, cleantech, fellowships Wade Roush wrote: It’s hard to kick-start a new regional industry if there’s a shortage of entrepreneurs who understand the business. That’s the problem the New England Clean Energy Council (NECEC) is taking on with a new fellowship program designed t...

VC, entrepreneurship, The Funded Robert Buderi wrote: Gossip and the inside dope are hard to resist—especially when they pertain to people who might hold your company’s fate in the palm of their hands. So, when you think about it, it was only a matter of time before the controversial web...

Web 2.0, RSS, Internet Wade Roush wrote: Ahh, Boston in springtime. Duck boat armadas on the Charles. The vinegary smell of the wood-chip mulch landscapers spread everywhere. Tow trucks hauling away cars so that street sweepers can get at the dead leaves accumulating since October. A guy on a recumb...

acquisitions, deals, Biotech Rebecca Zacks wrote: For months now we’ve been hearing rumors about big pharma planning a shopping spree among Cambridge’s biotechs, but I’ve got to admit we didn’t see this particular deal coming. Millennium Pharmaceuticals (NASDAQ: MLNM) has bee...